|中文 EN ES DE FR|
|Communication Through Translation|
The translation of medical documentation for clinical trials requires a high level of accuracy. Translation errors can have a serious impact on the meaning of documents. It is common practice for some committees (Helsinki-compliant documents, Institutional Review Boards [IRBS]) to require the clinical trial sponsor to deliver a back translation along with the forward translations.
Back translation adds a final step to the process in which a second translator takes the translated text and retranslates it back into the original language. The two original versions and the back translation are then compared to validate the accuracy of the content and to avoid inconsistencies, omissions and errors in the translated texts.
FiTranslation offers back translation services for the certification of clinical protocols, informed consents and other key medical documents for CROs and the pharmaceutical and medical device industries.
Request for Price Quote